弥散性血管内凝血与脓毒性休克患者严重急性肾损伤强相关
这项前瞻性单中心队列研究纳入350例脓毒性休克成人患者,其中129例发生DIC。DIC患者病情更重(中位SAPS II 64 vs. 56,p<0.001),28天死亡率更高(43.3% vs. 26.2%,p<0.001)。AKI在DIC患者中更常见(86.8% vs. 74.2%,p<0.005),KDIGO 3期占58.1% vs. 30.8%(p<0.001),需要肾脏替代治疗者占47.3% vs. 21.3%(p<0.001)。调整混杂因素后,DIC仍与更严重AKI(OR 2.74,95%CI 1.53-4.91,p<0.001)及ICU期间需要RRT(OR 2.82,95%CI 1.53-5.2,p<0.001)相关。
要点
- 脓毒性休克合并DIC患者KDIGO 3期AKI发生率为58.1%,显著高于无DIC患者的30.8%(p<0.001)。
- DIC患者需要肾脏替代治疗的比例为47.3%,无DIC患者为21.3%(p<0.001)。
- 调整混杂因素后,DIC与更严重AKI独立相关(OR 2.74,95%CI 1.53-4.91,p<0.001)。
- 调整后DIC与ICU期间需要RRT独立相关(OR 2.82,95%CI 1.53-5.2,p<0.001)。
- DIC患者病情更重(中位SAPS II 64 vs. 56,p<0.001),28天死亡率更高(43.3% vs. 26.2%,p<0.001)。
适用人群与场景
- 斯特拉斯堡大学医院ICU连续收治的18岁及以上、因感染导致全身性低血压需要血管加压药的脓毒性休克患者,且无终末期慢性肾病病史。
- 仅纳入DIC发生在AKI诊断之前或同时的患者。
诊断标准与关键阈值
- AKI根据KDIGO分类定义。
- DIC诊断基于国际血栓与止血学会(ISTH)评分。
研究设计与关键结果
- 研究类型:前瞻性单中心队列研究,纳入350例患者,其中129例发生DIC。
- DIC患者中位SAPS II为64,无DIC患者为56(p<0.001)。
- DIC患者28天死亡率为43.3%,无DIC患者为26.2%(p<0.001)。
- AKI在DIC患者中发生率为86.8%,无DIC患者为74.2%(p<0.005)。
- KDIGO 3期AKI在DIC患者中占58.1%,无DIC患者中占30.8%(p<0.001)。
- 需要肾脏替代治疗(RRT)的AKI在DIC患者中占47.3%,无DIC患者中占21.3%(p<0.001)。
- 调整混杂因素后,DIC与更严重AKI风险相关(OR 2.74,95%CI 1.53-4.91,p<0.001),与ICU期间需要RRT风险相关(OR 2.82,95%CI 1.53-5.2,p<0.001)。
证据类型、等级与局限
- 证据类型:前瞻性单中心队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在脓毒性休克患者中,若发生DIC(ISTH评分诊断),应警惕更严重AKI(KDIGO 3期)及需要RRT的风险显著升高。
- DIC患者病情更重、28天死亡率更高,提示需加强肾脏功能监测与支持治疗准备。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Disseminated intravascular coagulation (DIC) worsens the prognosis of septic shock and contributes to multiple organ failure. To date, no data linking DIC and acute kidney injury (AKI) occurrence, severity, and evolution in this setting are available. We aimed at analyzing the association between AKI occurrence, severity and evolution in patients with septic shock-induced DIC. In a prospective monocentric cohort study, consecutive patients, 18 years and older, admitted in the ICU of Strasbourg University Hospital in the setting of systemic hypotension requiring vasopressor related to an infection, without history of terminal chronic kidney disease were eligible. AKI was defined according to the KDIGO classification. DIC diagnosis was based on the International Society on Thrombosis and Haemostasis (ISTH) score. Evolution of AKI was evaluated through the composite endpoint of major adverse kidney events. Only patients with DIC that occurred before or at the time of AKI diagnosis were considered. Univariate and multivariate analysis were performed to determine factors associated with renal outcomes.
RESULTS: 350 patients were included, of whom 129 experienced DIC. Patients with DIC were more seriously ill (median SAPS II 64 vs. 56, p < 0.001), and had higher 28-day mortality (43.3% vs. 26.2%, p < 0.001). AKI was more frequent in patients with DIC (86.8% vs. 74.2%, p < 0.005), particularly for the more severe stage of AKI [KDIGO 3 in 58.1% of patients with DIC vs. 30.8% of patients without DIC, p < 0.001, AKI requiring renal replacement therapy (RRT) in 47.3% of patients with DIC vs. 21.3% of patients without DIC, p < 0.001]. After adjustment for confounding factors, DIC occurrence remained associated with the risk of having the more severe stage of AKI with an odds ratio (OR) of 2.74 [IC 95% (1.53-4.91), p < 0.001], and with the risk of requiring RRT during the ICU stay [OR 2.82 (1.53-5.2), p < 0.001].
CONCLUSION: DIC appears to be strongly associated with the risk of developing the more severe form of AKI (stage 3 of the KDIGO classification, RRT requirement), even after adjustment for severity and other relevant factors.
参考来源
- Helms J, Merdji H, Loewert S, et al. Disseminated intravascular coagulation is strongly associated with severe acute kidney injury in patients with septic shock. Ann Intensive Care. 2023. PMID: 38038826. doi:10.1186/s13613-023-01216-8
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。